BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv5.22.0.1711693755//EN
X-ORIGINAL-URL:https://ibdhorizons.org/
BEGIN:VEVENT
UID:MEC-07c5807d0d927dcd0980f86024e5208b@ibdhorizons.org
DTSTART:20200307T080000Z
DTEND:20200307T180000Z
DTSTAMP:20201120T185500Z
CREATED:20201120
LAST-MODIFIED:20201120
SUMMARY:5th IBDH Annual Symposium
DESCRIPTION:\n\nLearning Objectives\n\n\n\n\nReview the common extraintestinal manifestations in IBD apply practical approach to screen and intervene as needed\nAppraise the currently available evidence of the effect of Cannabis and supplements in IBD\nDiscuss the newly approved and soon to be approved biologic and non-biologic therapies for IBD, including the risks, efficacy and special considerations when utilizing these therapies\nDescribe and understand the comparative efficacy of the currently available therapies and the rationale for optimal positioning of these options in IBD today\nIncorporate the concept of treat to target in IBD clinical practice and evaluate effectively how to incorporate into IBD management and goals of care\nExamine the current management of fibrostenotic Crohn’s complications and apply best up-to-date medical and surgical treatment strategies\nApply up-to-date practice in managing dysplasia in IBD from detection to endoscopic and surgical intervention\nIdentify the most promising therapies including antibodies and small molecules in late-stage clinical development, with an emphasis on immunological targets and pharmacological properties\n\n\n
X-ALT-DESC;FMTTYPE=text/html:Learning Objectives